Abstracts

BINDING SIGNATURES AND CROSS-REACTIVITY IN THE SARS-CoV-2 IMMUNE RESPONSE

Mounting evidence indicates that antibodies generated during SARS-CoV-2 infection are correlates of protection. Antibodies targeting Spike (S) on the viral surface have been shown to neutralize the virus. However, the full repertoire of neutralizing and non-neutralizing antibodies against SARS-CoV-2, as well as cross-reactivity between SARS-CoV-2 and other circulating (CoVs), remains unclear. We sought to profile…

CHARACTERIZATION OF SARS-CoV-2–SPECIFIC RESPONSES IN PEOPLE LIVING WITH HIV

There is an urgent need to understand the nature of immune responses mounted against SARS-CoV-2, in order to better inform risk-mitigation and vaccine strategies for people living with HIV (PLWH). Although not all PLWH are considered immunosuppressed, residual cellular immunodeficiency could influence COVID-19 disease severity and the evolution and durability of protective immunity. Information on…

HIGH-RESOLUTION MAPPING OF T-CELL IMMUNITY TO THE ENTIRE SARS-CoV-2 PROTEOME

Since the discovery of SARS-CoV-2, researchers have put major efforts towards the understanding of virus-specific cellular immunity. However, the identification of epitope- and protein specific T-cell responses is limited to bioinformatic approaches, use of total viral proteins or peptide mega pools. To overcome these current limitations, we performed a high-resolution mapping using IFN-y ELISpot and…

T-CELL IMMUNE DYSREGULATION AND MORTALITY IN WOMEN WITH HIV

Dysregulation of adaptive immunity is a hallmark of HIV infection that persists even on antiretroviral therapy (ART), and may contribute to higher risk of non-HIV-related diseases in people with HIV compared to people without HIV. Yet few large, prospective studies with long follow-up have examined associations of adaptive immunity deficits with mortality in HIV. Multiparameter…

EARLY ART INITIATION MAY PRESERVE INFLUENZA VACCINE RESPONSE DURABILITY

Aging and immunosenescence predict poor influenza vaccine responsiveness. We sought to determine whether treated HIV is also associated with poor vaccine responsiveness, and if delayed antiretroviral therapy (ART) initiation or persistent immune activation affect vaccine response in this setting. People with HIV (PWH) with ART-mediated viral suppression >1 year and HIV- controls, all CMV+ and…

NEUTRALIZING-ANTIBODY RESPONSES FOLLOWING SARS-CoV-2 INFECTION

Understanding the adaptive immune response to SARS-CoV-2, kinetics, persistence and their relationship with the disease severity would be crucial in order to predict recurrences, reinfections and could serve in the design of vaccination strategies. We sought to characterize IgG and neutralizing antibodies (NAbs) against SARS-CoV-2 in patients who were admitted to hospital with COVID-19 disease.…

SARS-CoV-2 NEUTRALIZING-ANTIBODY RESPONSES IN CONVALESCENT INDIVIDUALS IN US AND PERU

SARS-CoV-2 has claimed over a million lives and remains a global threat. Understanding immune responses to infection and developing validated laboratory assays to measure them is critical to the rapid development, assessment and implementation of effective interventions. Our development of a validated pseudovirus neutralization assay and characterization of neutralizing antibody (nAb) profiles in a diverse…